Two leading US-based autism centres have joined Blinklab’s autism diagnostic registrational trial. ... Read More The post ...

A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

The Hong Kong University of Science and Technology (HKUST) has recently established strategic partnership with The First ...

Aintree’s urgent care and trauma centre contains the hospital’s emergency department, major trauma, critical care services and frailty assessment unit. Planning permission was granted last March to ...

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new ...

Non-invasive brain stimulation (NIBS) technologies are rapidly gaining prominence as effective tools for both investigating and modulating brain activity.

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational Research ...

Planning permission has been granted for a new £3.6m substance misuse centre. Proposals were submitted to Hartlepool ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...